Accelerating clinical evidence synthesis with large language models
Abstract Clinical evidence synthesis largely relies on systematic reviews (SR) of clinical studies from medical literature. Here, we propose a generative artificial intelligence (AI) pipeline named TrialMind to streamline study search, study screening, and data extraction tasks in SR. We chose publi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Digital Medicine |
| Online Access: | https://doi.org/10.1038/s41746-025-01840-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Abstract Clinical evidence synthesis largely relies on systematic reviews (SR) of clinical studies from medical literature. Here, we propose a generative artificial intelligence (AI) pipeline named TrialMind to streamline study search, study screening, and data extraction tasks in SR. We chose published SRs to build TrialReviewBench, which contains 100 SRs and 2,220 clinical studies. For study search, it achieves high recall rates (Ours 0.711–0.834 v.s. Human baseline 0.138–0.232). For study screening, TrialMind beats previous document ranking methods in a 1.5–2.6 fold change. For data extraction, it outperforms a GPT-4’s accuracy by 16–32%. In a pilot study, human-AI collaboration with TrialMind improved recall by 71.4% and reduced screening time by 44.2%, while in data extraction, accuracy increased by 23.5% with a 63.4% time reduction. Medical experts preferred TrialMind’s synthesized evidence over GPT-4’s in 62.5%-100% of cases. These findings show the promise of accelerating clinical evidence synthesis driven by human-AI collaboration. |
|---|---|
| ISSN: | 2398-6352 |